BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Biotech Bay

  Amarantus Subsidiary Elto Pharma Announces the Issuance of Patents in Singapore and New Zealand Covering Treatment of Parkinson’s LID

  Both patents are titled “Treatment of Motor Symptoms and Movement Disorder Side Effects Associated with Parkinson’s disease treatments,” and are valid into 2033.

  December 8, 2017

   · 

  4 min read
• Genetown

  Exergen Reaches New Milestone: Temporal Artery Thermometers Now Used by More Nurses Than Any Other Type of Thermometer

  Exergen is changing the way the world takes temperature.

  December 8, 2017

   · 

  1 min read
• Business

  Prime Therapeutics Signs Outcomes-Based Contract With Novo Nordisk for Type 2 Diabetes Drug Victoza (liraglutide)

  This new contract with Novo Nordisk for Victoza aligns to Prime’s strategy by focusing on controlling overall costs for members.

  December 8, 2017

   · 

  3 min read
• 

  Drug Development

  ERYTECH’s Lead AML Drug Flunks Phase II Test

  The study enrolled a total of 123 patients at 30 European sites.

  December 8, 2017

   · 

  7 min read
• Bio NC

  Fennec Announces Proposed Public Offering of Common Shares

  In addition, Fennec intends to grant the underwriters a 30-day option to purchase up to an additional 15% of its common shares offered in the public offering.

  December 8, 2017

   · 

  4 min read
• BioMidwest

  Skyline Medical Issues Letter to Shareholders

  The company laid out some of the plans Skyline’s management team has been working toward over the past several months.

  December 8, 2017

   · 

  10 min read
• Business

  Medline, ROi Announce Two New Agreements on Traditional Wound Care and Incontinence Products

  The three-year collaboration will take effect on Feb. 1, 2018.

  December 8, 2017

   · 

  2 min read
• 

  Drug Development

  Lilly’s Cyramza Fails to Improve Overall Survival in Phase III Gastric Cancer Study

  The trial met its primary endpoint of progression-free survival but did not improve overall survival, a secondary endpoint.

  December 8, 2017

   · 

  22 min read
• Business

  The Cooper Companies Announces Fourth Quarter and Full Year 2017 Results

  Fourth quarter revenue increased 8% year-over-year to $561.5 million. Fiscal 2017 revenue increased 9% to $2,139.0 million.

  December 8, 2017

   · 

  22 min read
• BioCapital

  QIAGEN to Transfer U.S. Listing of Global Shares to NYSE

  QIAGEN N.V. today announced that it is transferring the U.S. listing of its global shares to the NYSE from the NASDAQ Global Market.

  December 8, 2017

   · 

  1 min read